Optimal Immunosuppression Strategy in the Sensitized Kidney Transplant Recipient
Patients with previous sensitization events against anti-human leukocyte antigens (HLA) often have circulating anti-HLA antibodies. Following organ transplantation, sensitized patients have higher rates of antibody-mediated rejection (AMR) compared to those who are non-sensitized. More stringent don...
Main Authors: | Danae Olaso, Miriam Manook, Dimitrios Moris, Stuart Knechtle, Jean Kwun |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/16/3656 |
Similar Items
-
Low-dose alemtuzumab induction in a tailored immunosuppression protocol for sensitized kidney transplant recipients
by: Martina Guthoff, et al.
Published: (2020-05-01) -
Emerging New Approaches in Desensitization: Targeted Therapies for HLA Sensitization
by: Ashley Y. Choi, et al.
Published: (2021-06-01) -
Comparative analysis of induction immunosuppressive therapy protocols in renal transplant recipients (retrospective review)
by: Sh. R. Galeev, et al.
Published: (2020-07-01) -
Single-Cell Profiling of Kidney Transplant Recipients With Immunosuppressive Treatment Reveals the Dynamic Immune Characteristics
by: Yongguang Liu, et al.
Published: (2021-04-01) -
Modulation of maintenance immunosuppression during infection in renal transplant recipients
by: M Edwin Fernando, et al.
Published: (2018-01-01)